INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE;UNIVERSITE CLAUDE BERNARD LYON 1;INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE LYON;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;LIPTHER
The present invention relates to AceFaPC (1-Acetyl-2-Fatty acyl-glyceroPhosphoCholine) for use in the prevention and treatment of diseases associated with an acetylcholine deficiency. The invention also relates to the AceFaPC molecule in which Fa represents an unsaturated acyl comprising at least 14 carbon atoms, and the pharmaceutical compositions comprising same.